These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


100 related items for PubMed ID: 2905645

  • 41. Characterization of enhanced behavioral responses to L-DOPA following repeated administration in the 6-hydroxydopamine-lesioned rat model of Parkinson's disease.
    Henry B, Crossman AR, Brotchie JM.
    Exp Neurol; 1998 Jun; 151(2):334-42. PubMed ID: 9628768
    [Abstract] [Full Text] [Related]

  • 42. Dogma disputed: is tardive dyskinesia due to postsynaptic dopamine receptor supersensitivity?
    Jeste DV, Wyatt RJ.
    J Clin Psychiatry; 1981 Dec; 42(12):455-7. PubMed ID: 6118358
    [Abstract] [Full Text] [Related]

  • 43. A blinded study of the suppressibility of involuntary movements in Huntington's chorea, tardive dyskinesia, and L-dopa-induced chorea.
    Walters AS, McHale D, Sage JI, Hening WA, Bergen M.
    Clin Neuropharmacol; 1990 Jun; 13(3):236-40. PubMed ID: 2141544
    [Abstract] [Full Text] [Related]

  • 44. [Late dyskinesias. Clinical aspects, pathophysiology, therapy].
    Brücher K.
    Dtsch Med Wochenschr; 1984 Oct 05; 109(40):1533-7. PubMed ID: 6148229
    [No Abstract] [Full Text] [Related]

  • 45. [Oral dyskinesis, facial dystonia].
    Nakamura S, Akiguchi I.
    Nihon Rinsho; 1993 Nov 05; 51(11):2978-82. PubMed ID: 8277580
    [Abstract] [Full Text] [Related]

  • 46. Tardive dyskinesia.
    Clyne KE, Juhl R.
    Am J Hosp Pharm; 1976 May 05; 33(5):481-6. PubMed ID: 1274963
    [Abstract] [Full Text] [Related]

  • 47. Facial dyskinesias.
    Kaufman DM.
    Psychosomatics; 1989 May 05; 30(3):263-9. PubMed ID: 2669010
    [Abstract] [Full Text] [Related]

  • 48. Therapeutic response to progabide in neuroleptic- and L-dopa-induced dyskinesias.
    Ziegler M, Fournier V, Bathien N, Morselli PL, Rondot P.
    Clin Neuropharmacol; 1987 Jun 05; 10(3):238-46. PubMed ID: 2900682
    [Abstract] [Full Text] [Related]

  • 49. [Drug-induced movement disorders].
    Velázquez-Pérez JM, Marsal-Alonso C.
    Rev Neurol; 2009 Jan 23; 48 Suppl 1():S57-60. PubMed ID: 19222017
    [Abstract] [Full Text] [Related]

  • 50. [Bucco-linquo-facial and choriform hyperkinesies (author's transl)].
    Trillet M, Laurent B.
    Sem Hop; 2009 Jan 23; 54(37-40):1159-63. PubMed ID: 33450
    [Abstract] [Full Text] [Related]

  • 51. Identification and management of tardive dyskinesia: A case series and literature review.
    Khouzam HR.
    Postgrad Med; 2015 Jan 23; 127(7):726-37. PubMed ID: 26216578
    [Abstract] [Full Text] [Related]

  • 52. [Abnormal movements, tardive dyskinesias].
    Herrero Botín M.
    Rev Enferm; 1990 Apr 23; 13(140):58-60. PubMed ID: 2356413
    [No Abstract] [Full Text] [Related]

  • 53. Tardive stereotypy and other movement disorders in tardive dyskinesias.
    Stacy M, Cardoso F, Jankovic J.
    Neurology; 1993 May 23; 43(5):937-41. PubMed ID: 8492949
    [Abstract] [Full Text] [Related]

  • 54. Tardive dyskinesia: nondopaminergic treatment approaches.
    Casey DE.
    Psychopharmacology Suppl; 1985 May 23; 2():137-44. PubMed ID: 2860657
    [Abstract] [Full Text] [Related]

  • 55. Clinical manifestations of tardive truncal dystonia--abdominal movements: report of two cases.
    Shan DE, Liao KK, Fuh JL.
    Zhonghua Yi Xue Za Zhi (Taipei); 1998 Sep 23; 61(9):545-50. PubMed ID: 9798304
    [Abstract] [Full Text] [Related]

  • 56. Pharmacological characterization of tardive dyskinesia.
    Casey DE, Denney D.
    Psychopharmacology (Berl); 1977 Aug 31; 54(1):1-8. PubMed ID: 410053
    [Abstract] [Full Text] [Related]

  • 57. Orofacial dyskinesias and dystonia in rats infected with Borna disease virus; a model for tardive dyskinetic syndromes.
    Solbrig M, Koob G, Lipkin W.
    Mol Psychiatry; 1999 Jul 31; 4(4):310-2. PubMed ID: 10483043
    [Abstract] [Full Text] [Related]

  • 58. GABA system, GABA receptor agonists and dyskinesia.
    Bartholini G.
    Mod Probl Pharmacopsychiatry; 1983 Jul 31; 21():143-54. PubMed ID: 6318094
    [No Abstract] [Full Text] [Related]

  • 59. Fluphenazine-induced acute and tardive dyskinesias in monkeys.
    Kovacic B, Domino EF.
    Psychopharmacology (Berl); 1984 Jul 31; 84(3):310-4. PubMed ID: 6440175
    [Abstract] [Full Text] [Related]

  • 60. GABAmimetic treatments for tardive dyskinesia: efficacy and mechanism.
    Tamminga CA, Thaker GK, Nguyen JA.
    Psychopharmacol Bull; 1989 Jul 31; 25(1):43-6. PubMed ID: 2672071
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 5.